ID: ALA5171815

Max Phase: Preclinical

Molecular Formula: C31H40N4

Molecular Weight: 468.69

Associated Items:

Representations

Canonical SMILES:  c1cc2nc3c(cc2cc1CCCN1CCCCC1)[nH]c1ccc(CCCN2CCCCC2)cc13

Standard InChI:  InChI=1S/C31H40N4/c1-3-15-34(16-4-1)19-7-9-24-11-13-28-26(21-24)23-30-31(33-28)27-22-25(12-14-29(27)32-30)10-8-20-35-17-5-2-6-18-35/h11-14,21-23,32H,1-10,15-20H2

Standard InChI Key:  ZUZZUSCYXNBGTB-UHFFFAOYSA-N

Associated Targets(Human)

Telomerase reverse transcriptase 2428 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 468.69Molecular Weight (Monoisotopic): 468.3253AlogP: 6.71#Rotatable Bonds: 8
Polar Surface Area: 35.16Molecular Species: BASEHBA: 3HBD: 1
#RO5 Violations: 1HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski): 1
CX Acidic pKa: 13.07CX Basic pKa: 10.05CX LogP: 6.68CX LogD: 2.04
Aromatic Rings: 4Heavy Atoms: 35QED Weighted: 0.31Np Likeness Score: -0.46

References

1. Nuthakki VK, Mudududdla R, Bharate SB..  (2022)  Role of basic aminoalkyl chains in the lead optimization of Indoloquinoline alkaloids.,  227  [PMID:34710743] [10.1016/j.ejmech.2021.113938]

Source